Skip to main content
logo
Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
29.27
+0.47 (1.63%)
Jul 28, 2026, 1:33 PM EDT - Market open

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Denmark Revenue
3.33B2.87B
Netherlands Revenue
1.00M-
United States Revenue
180.00M131.00M
Japan Revenue
213.00M122.00M
Revenue (Total)
3.72B3.12B

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
DARZALEX Royalties Revenue
2.44B2.02B
Kesimpta Royalties Revenue
443.00M323.00M
TEPEZZA Royalties Revenue
105.00M106.00M
Other Product Royalties Revenue
111.00M69.00M
Total Royalties Revenue
3.10B2.52B
Net Product Sales
398.00M253.00M
Reimbursement Revenue
53.00M144.00M
Milestone Revenue
97.00M145.00M
Collaboration Revenue
70.00M62.00M
Revenue (Other)
-3.10B-2.52B
Revenue (Total)
3.72B3.12B

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
J&J Revenue
2.57B2.09B
AbbVie Revenue
66.00M58.00M
Roche Revenue
106.00M107.00M
Novartis Revenue
446.00M408.00M
BioNTech Revenue
40.00M127.00M
Pfizer Revenue
77.00M77.00M
Other Collaboration Partner Revenue
22.00M-
Revenue (Total)
3.72B3.12B